Publications

• The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador.

  (Campos NG, Alfaro K, Maza M, Sy S, Melendez M, Masch R, Soler M, Conzuelo-Rodriguez G, Gage JC, Alonzo TA, Castle PE, Felix JC, Cremer M, Kim JJ.) Prev Med. 2020 02;131:105931 PMID: 31765712 11/26/2019

• Evaluation of two alternative ablation treatments for cervical pre-cancer against standard gas-based cryotherapy: a randomized non-inferiority study.

  (Cremer M, Alfaro K, Garai J, Salinas M, Maza M, Zevallos A, Taxa L, Diaz AC, Castle P, Alonzo TA, Masch R, Soler M, Conzuelo-Rodriguez G, Gage JC, Felix JC.) Int J Gynecol Cancer. 2019 May 03 PMID: 31055452 05/06/2019

• The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador.

  (Campos NG, Maza M, Alfaro K, Gage JC, Castle PE, Felix JC, Masch R, Cremer M, Kim JJ.) Int J Gynaecol Obstet. 2019 Apr;145(1):40-46 PMID: 30702142 PMCID: PMC6988124 02/01/2019

• Acceptability of self-sampling and human papillomavirus testing among non-attenders of cervical cancer screening programs in El Salvador.

  (Maza M, Melendez M, Masch R, Alfaro K, Chacon A, Gonzalez E, Soler M, Conzuelo-Rodriguez G, Gage JC, Alonzo TA, Castle PE, Felix JC, Cremer M.) Prev Med. 2018 09;114:149-155 PMID: 29958860 07/01/2018

• Effects of Maintenance on Quality of Performance of Cryotherapy Devices for Treatment of Precancerous Cervical Lesions.

  (Maza M, Figueroa R, Laskow B, Juárez A, Alfaro K, Alonzo TA, Felix JC, Gage JC, Cremer M.) J Low Genit Tract Dis. 2018 01;22(1):47-51 PMID: 29271857 12/23/2017

• A Complication of Percutaneous Sclerotherapy for Congenital Pulmonary Airway Malformation: Intravascular Injection and Cardiac Necrosis.

  (H Chon A, Takeda MR, Felix JC, Chmait RH.) Fetal Pediatr Pathol. 2017 Dec;36(6):437-444 PMID: 29206544 12/06/2017

• Cervical cancer prevention in El Salvador (CAPE)-An HPV testing-based demonstration project: Changing the secondary prevention paradigm in a lower middle-income country.

  (Maza M, Alfaro K, Garai J, Velado MM, Gage JC, Castle PE, Felix J, Luciani S, Campos N, Kim J, Masch R, Cremer M.) Gynecol Oncol Rep. 2017 May;20:58-61 PMID: 28337474 PMCID: PMC5352717 03/25/2017

• Scale-Up of an Human Papillomavirus Testing Implementation Program in El Salvador.

  (Cremer M, Maza M, Alfaro K, Morales Velado M, Felix J, Castle PE, Kim J, Gage JC.) J Low Genit Tract Dis. 2017 Jan;21(1):26-32 PMID: 27922905 PMCID: PMC5201413 12/07/2016

• The Clinical and Economic Benefits of Co-Testing Versus Primary HPV Testing for Cervical Cancer Screening: A Modeling Analysis.

  (Felix JC, Lacey MJ, Miller JD, Lenhart GM, Spitzer M, Kulkarni R.) J Womens Health (Larchmt). 2016 06;25(6):606-16 PMID: 27023044 PMCID: PMC4900245 03/30/2016

• mRNA-based hrHPV assay in cotesting for cervical cancer screening.

  (Felix J.) MLO Med Lab Obs. 2016 Apr;48(4):22-3 PMID: 27188021 05/18/2016

• Introducing a High-Risk HPV DNA Test Into a Public Sector Screening Program in El Salvador.

  (Cremer ML, Maza M, Alfaro KM, Kim JJ, Ditzian LR, Villalta S, Alonzo TA, Felix JC, Castle PE, Gage JC.) J Low Genit Tract Dis. 2016 Apr;20(2):145-50 PMID: 26890683 PMCID: PMC4819528 02/19/2016

• Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol.

  (Hodis HN, Mack WJ, Henderson VW, Shoupe D, Budoff MJ, Hwang-Levine J, Li Y, Feng M, Dustin L, Kono N, Stanczyk FZ, Selzer RH, Azen SP, ELITE Research Group.) N Engl J Med. 2016 Mar 31;374(13):1221-31 PMID: 27028912 PMCID: PMC4921205 03/31/2016